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Abstract
Pkd1 localizes to primary cilia in osteoblasts and osteocytes. Targeted deletion of Pkd1 in osteoblasts results in osteopenia
and abnormalities in Runx2-mediated osteoblast development. Kif3a, an intraflagellar transport protein required for cilia
function, is also expressed in osteoblasts. To assess the relationship between Pkd1 and primary cilia function on bone
development, we crossed heterozygous Pkd1- and Kif3a-deficient mice to create compound Pkd1 and Kif3a-deficient mice.
Pkd1 haploinsufficiency (Pkd1
+/D) resulted in osteopenia, characterized by decreased bone mineral density, trabecular bone
volume, and cortical thickness. In addition, deficiency of Pkd1 resulted in impaired osteoblastic differentiation and
enhanced adipogenesis in both primary osteoblasts and/or bone marrow stromal cell cultures. These changes were
associated with decreased Runx2 expression, increased PPARc expression, and impaired hedgehog signaling as evidenced
by decreased Gli2 expression in bone and osteoblast cultures. In contrast, heterozygous Kif3a
+/D mice display no
abnormalities in skeletal development or osteoblast function, but exhibited decreased adipogenic markers in bone and
impaired adipogenesis in vitro in association with decreased PPARc expression and upregulation of Gli2. Superimposed Kif3a
deficiency onto Pkd1
+/D mice paradoxically corrected the effects of Pkd1 deficiency on bone mass, osteoblastic
differentiation, and adipogenesis. In addition, Runx2, PPARc and Gli2 expression in bone and osteoblasts were normalized in
compound double Pkd1
+/D and Kif3a
+/D heterozygous mice. The administration of sonic hedgehog, overexpression of Gli2,
and the PC1 C-tail construct all increased Gli2 and Runx2-II expression, but decreased PPARc2 gene expression in C3H10T1/2
cells. Our findings suggest a role for Pkd1 and Kif3a to counterbalance the regulation of osteogenesis and adipogenesis
through differential regulation of Runx2 and PPARc by Gli2.
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Introduction
The primary cilium is a microtubule-based membrane protru-
sion that is assembled and maintained by the bidirectional
intraflagellar transport (IFT) machinery [1] that is involved in
the differentiation of mesenchymal stem cells into osteoblasts,
chondrocytes and adipocytes. In this regard, disruption of primary
cilia results in abnormal skeletal patterning, post-natal growth
plate development, and skeletogenesis [2,3,4,5,6]. Conditional
inactivation of kinesin family member 3A (Kif3a), a subunit of
kinesin-2 motor complex, in mesenchymal stem cells results in
severe patterning defects [3]. Conditional inactivation of Kif3a in
chondrocytes results in post-natal dwarfism due to premature loss
of the growth plate [2,4]. siRNA-mediated knock down of Kif3a in
3T3-L1 preadipocytes also leads to impaired adipocyte differen-
tiation [7]. Primary cilia have also been identified in the osteoblast
lineage and have been postulated to play a role in osteoblast
differentiation [8,9].
The mechanisms whereby primary cilia regulate mesenchymal
differentiation into the osteoblast lineage have not been defined.
Primary cilia house and transport several signaling molecules
involved in skeletogenesis and postnatal bone homeostasis
[10,11,12,13], including Patched (Ptch1)-Smoothened (Smo)-
Hedgehog (Hh)/Gli and polycystins complexes [5,14,15]. The
Ptch1-Smo-Hh/Gli pathway is initiated by Hh ligand binding to
Ptch1 in primary cilia, which releases the inhibition of Smo and
allows it to activate Gli transcription factors [15,16,17,18,
19,20,21]. Activation of hedgehog signaling and Gli2 results in
increased Runx2 expression and osteogenesis, but decreased
peroxisome proliferator-activated receptor gamma (PPARc) ex-
pression and adipogenesis [20,22,23,24].
Primary cilia and polycystins are co-expressed in cells within the
osteoblast lineage [8] where they have been postulated to regulate
skeletogenesis [4,9,25,26,27]. Although polycystin-1 (PC1), encod-
ed by the Pkd1 gene, and Polycystin-2 (PC2), encoded by the Pkd2
gene, are mutated in autosomal dominant polycystic kidney
disease [28,29,30,31], loss of polycystin function in mice also
causes a severe skeletal phenotype. In this regard, homozygous loss
of PC1 is associated with abnormal skeletal development through
stimulation of the osteoblast-specific transcription factor Runx2-II
[8,33]. Skeletal abnormalities are also observed in heterozygous
Pkd1 mutant mice [8]. Moreover, Osteocalcin-Cre mediated
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results in osteopenia due to decreased osteoblast-mediated bone
formation. Conditional deletion of Pkd1 in osteoblasts also results
in increased adipogenesis in bone marrow stromal cell and
impaired osteoblast differentiation, indicating that Pkd1 may also
play a role in controlling a differentiation switch between the
osteoblast and adipocyte lineages [34].
Primary cilia and polycystins are functionally interconnected in
many tissues. For example, loss of PC1 or primary cilia in the
kidney results in same cystic phenotype. Indeed, polycystic disease
can be caused in mouse models by homozygous loss-of-function
mutations in proteins required for cilia formation or function, such
as TG737, Kif3a, fibrocystin, and cystin [35,36,37,38]. Whether
polycystins and primary cilia have interdependent functions in
skeletogenesis is not known.
In the current study, we sought to examine if PC1 and primary
cilia have interdependent functions in osteoblast and bone
development. We crossed heterozygous Pkd1-deficient mice onto
heterozygous Kif3a-deficient mice to create double heterozygous
Pkd1 and Kif3a-deficient mice in an effort to impair both PC1 and
primary cilia function. Unexpectedly, Kif3a deficiency upregulated
Hh signaling and reversed the effect of mutant Pkd1 to impair
osteoblastic differentiation and stimulate adipogenesis in vivo and in
vitro. These effects on bone development occurred through cross-
talk between Pkd1 and Hh pathways at the level of Gli2 expression
in bone and osteoblasts. Thus, we have discovered a new
interaction between Hh and Pkd1 components of primary cilia.
Results
Confirmation of Pkd1 and Kif3a deficiency in vivo and in
vitro
Since homozygous Pkd1 and Kif3a null mice are embryonic
lethal [32,39,40], we examined compound heterozygous Pkd1 and
Kif3a deficient mice to establish a potential functional link between
Pkd1 and Kif3a. Crossing heterozygous Pkd1
+/D mice with
heterozygous Kif3a
+/D mice generated four genotypes that were
born with the expected Mendelian frequency, including wild-type,
heterozygous Pkd1
+/D, heterozygous Kif3a
+/D, and double hetero-
zygous (Pkd1
+/D;Kif3a
+/D) mice (Fig. 1B). The overall survival and
body weight of single heterozygous and double heterozygous
Pkd1
+/D and Kif3a
+/D mice was not different from wild-type
littermates. There was no evidence of cyst formation in kidneys of
either single or double heterozygous mice (data not shown).
Real-time RT-PCR analysis revealed that the expression of total
Pkd1 or Kif3a transcripts from tibias of single heterozygous mice
was reduced ,50% at six weeks of age compared to wild-type
control (Fig. 1C), consistent with the deficiency of a single Pkd1
+/D
or Kif3a
+/D allele. The expression of Pkd1 or Kif3a transcripts in
tibias of double heterozygous Pkd1
+/D;Kif3a
+/D was reduced to the
same degree as their respective single heterozygous mice (Fig. 1C).
We found that primary osteoblast cultures derived from
heterozygous Kif3a mice had an approximately 50,60% reduc-
tion in mRNA expression levels of Kif3a transcripts (Fig. 1D).
Although homozygous disruption of Kif3a disables anterograde
IFT and leads to failure in the formation and maintenance of cilia
[39], heterozygous disruption of Kif3a had no effect on
ciliogenesis. Indeed, neither the reduction in Pkd1 or/and Kif3a
altered the appearance of primary cilia in cultured osteoblasts (Fig.
1E and 1F).
Lack of an effect of Kif3a deficiency on skeletogenesis
We found that heterozygous Kif3a
+/D mice had no demonstrable
bone abnormalities (Fig. 2). Indeed, the Kif3a
+/D mice had both
normal bone mineral density (BMD) and bone structure compared
with age-matched wild-type control mice (Fig. 2A and 2B). In
addition, bone samples from single heterozygous Kif3a
+/D mice
had no detectable changes in markers of osteoblasts or osteoclasts
(Table 1). Primary osteoblasts derived from Kif3a
+/2 mice
underwent an osteoblast differentiation and mineralization
program similar to wild-type derived cells (Fig. 3A–C). Kif3a
deficiency, however, resulted in significant reductions in adipo-
cyte-related markers, including adipocyte-specific fatty acid binding
protein (aP2), lipoprotein lipase (Lpl), and Adiponectin in long bone
samples (Fig. 3D).
Pkd1 deficiency induces osteopenia due to impaired
osteoblast differentiation
We observed osteopenia in heterozygous Pkd1
+/D mice, similar
to previously described heterozygous Pkd1
m1Bei mutant mice [8].
Indeed, haploinsufficiency of Pkd1 expression in bone tissues
resulted in a ,10% reduction in femoral BMD in both male and
female adult mice (Fig. 2A). Micro-computed tomography (mCT)
analysis revealed that the reduction in bone mass in single Pkd1
+/D
mice was caused by a reduction in trabecular bone volume (BV/
TV, 29%) and cortical bone thickness (CtTh, 14%) (Fig. 2B).
These reductions in bone volume and cortical thickness were
associated with a significant decrease in mineral apposition rate in
single Pkd1
+/D mice compared with age-matched control (Fig. 2C).
We also found that low bone formation rates rather than
increased bone resorption contributed to ostepenia in Pkd1
+/D mice.
In this regard, bone derived from single heterozygous Pkd1
+/D mice
had significant reductions in the osteoblast-lineage gene transcripts,
including Runx2, Osteocalcin, Osterix, Osteoprotegerin (Opg), Rank ligand
(RankL), and dentin matrix protein 1 (Dmp1) mRNA levels compared to
wild-type control mice (Table 1). The ratio of Opg/RankL that
favors reduced osteoclastogenesis, and the bone expression of
tartrate-resistant acid phosphatase (Trap), a marker of bone resorption,
was reduced in heterozygous Pkd1
+/D mice (Table 1). In contrast,
PPARc, Lpl, and Adiponectin but not aP2, markers of adipocyte
differentiation, were significantly increased in the tibia of hetero-
zygous Pkd1
+/D mice (Table 1). Serum levels of Osteocalcin and
TRAP were also reduced in 6-week-old heterozygous Pkd1
+/D mice
compared to wild-type littermates (Table 2).
Rescue of osteopenia, abnormal mineralization and
defective adipogenesis associated with Pkd1 deficiency
in compound Kif3a and Pkd1 deficient mice
Next, we assessed the effects of superimposed heterozygous
deficiency of Kif3a on BMD and bone structure in Pkd1-deficient
mice. Surprisingly superimposed Kif3a
+/D deficiency onto hetero-
zygous Pkd1
+/D mice corrected the skeletal phenotype observed in
single mutant Pkd1 deficient mice (Fig. 2). Heterozygous defici-
ency of Kif3a in Pkd1 deficient mice corrects the effects of Pkd1
deficiency to lower bone mass (Fig. 2A and 2B) and mineral
apposition rate (MAR) (Fig. 2C). In addition, compound
Pkd1
+/D;Kif3a
+/D heterozygous mice demonstrated normal expres-
sion of the osteoblastic, adipocytic and osteoclastic transcripts in
whole bone (Table 1). Both heterozygous Kif3a
+/D and compound
Pkd1
+/D;Kif3a
+/D heterozygous mice had no significant alterations
in serum markers of bone formation and resorption markers at 6
weeks of age compared with wild-type control (Table 2). The
apparent rescue of the Pkd1-mutant phenotype was not due to
differences in genetic background, since both Pkd1 and Kif3a
mutant mice had been crossed onto the C57BL/6J background for
multiple generations.
Regulation of Gli2 Expression by Kif3a and Pkd1
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15240Figure 1. Confirmation of Pkd1 and Kif3a deficiency and in vivo and in vitro. (A) Schematic illustration of wild-type (Pkd1
+) and deleted
(Pkd1
D) Pkd1 allele which has been removed the lox P cassette containing Exon 2–4 via Cre-mediated recombination (upper two panels), as well as
wild-type (Kif3a
+) and deleted (Kif3a
D) Kif3a allele which has been excised the lox P cassette containing Exon 2 via Cre-mediated recombination (lower
two panels). (B) Genotype PCR analysis of tail genomic DNA harvested from different individual mice. Four genotypes were generated in this
breeding strategy. (C–D) Real-time RT-PCR analysis of total Pkd1 and Kif3a transcripts from the tibias of 6-week-old mice (C) and the cultured primary
osteoblasts (D) by real-time RT-PCR. The level of Pkd1 or Kif3a transcripts exhibited almost ,50% decreases in long bone samples and primary
cultured osteoblasts from single Pkd1
+/D or Kif3a
+/D mice, and both Pkd1 and Kif3a transcripts retained the same reductions in compound
Pkd1
+/D;Kif3a
+/D mice compared with wild-type control mice. The value of Pkd1 or Kif3a vs. cyclophilin A from the indicated genotype was a fold
difference over wild-type. Data are expressed as the mean6SD from 5 to 6 individual mice. Values sharing the same superscript are not significantly
different at P,0.05. (E-F) Immunofluorescence of primary cilia in cultured primary osteoblasts. Immunostaining of primary cilia (Red) was performed
with acetylated a-tubulin antibody as described in the Materials and Methods. Counterstaining with a nuclear marker (DAPI blue) was used to
calculate the percentage presence of primary cilia in cultured primary osteoblasts. There were no obvious number differences in the primary cilia
among these four genotype osteoblasts.
doi:10.1371/journal.pone.0015240.g001
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PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15240Figure 2. Rescue of the skeletal phenotype in Pkd1-deficient mice by transfer onto Kif3a-deficient background. (A) Effects of Pkd1 or/
and Kif3a on BMD at 6 weeks of age. Compared with age-matched wild-type control, single heterozygous Pkd1
+/D mice had ,10% reduction in
femoral BMD in both male and female adult mice. In contrast, there were no significant changes in the BMDs in single heterozygous Kif3a
+/D mice,
but the bone mass totally become normal in double heterozygous Pkd1
+/D; Kif3a
+/D mice, indicating Kif3a deficiency predominates over effects of
Pkd1 deficiency on bone mass. The following data only represents male mice. (B) Effects of Pkd1 or/and Kif3a on bone structure of femoral
metaphyses and midshaft diaphyses. mCT analysis revealed that single heterozygous Kif3a
+/D mice exhibited a significant decrease in both BV/TV and
CtTh, single heterozygous Kif3a
+/D mice had no obvious changes in femoral bone structure, and Kif3a deficiency corrected the effects of Pkd1
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examined the impact of combined Pkd1 and Kif3a deficiency on
cell proliferation, osteoblastic differentiation, and gene expression
profiles in cells isolated from calvaria of newborn wild-type, single
heterozygous and compound heterozygous Pkd1 and Kif3a
deficient mice (Fig. 3). Cells isolated from calvaria are a mixed
population capable of differentiation into both osteogenic and
adipogenic pathways in culture [41,42]. We observed no
significant changes in 5-bromo-2-deoxyuridine (BrdU) incorpora-
tion of calvarial derived cells between the four genotypes (data not
shown), indicating neither Pkd1 nor Kif3a deficiency affected cell
proliferation. Concordant with defects in both osteoblast and
adipocyte developmental markers observed whole bone in vivo
(Table 1), we found that cultured calvarial cells derived from single
heterozygous Pkd1
+/D mice displayed lower alkaline phophatase
(ALP) activity (Fig. 3A) and diminished calcium deposition in
extracellular matrix (Fig. 3B), reduced osteoblastic gene expression
markers, such as Runx2 and Osteocalcin (Fig. 3C), and increased
adipogenic gene expression, including PPARc and aP2 (Fig. 3D)
compared to wild-type controls. Calvarial culture derived from
heterozygous Pkd1
+/D also demonstrated decreased phosphoryla-
tion of the Akt (Fig. 3E), consistent with our prior results showing
coupling of Pkd1 to the PI3K/Akt pathway in osteoblasts [43].
In contrast, single heterozygous Kif3a
+/D osteoblasts had no
abnormalities in ALP activity, mineralization of extracellular
matrix, or osteogenic gene expressions profiles (Fig. 3C–3E).
Consistent with the decreased adipogenic markers in whole bone
of Kif3a
+/D mice, however, calvarial derived cells from Kif3a
+/D
mice expressed significantly lower levels of PPARc and aP2
compared to wild-type controls.
The defective osteoblastic differentiation, mineral deposition,
and osteogenic gene expression in calvarial cultures derived Pkd1-
deficient mice was completely reversed by superimposing Kif3a
deficiency. Indeed, calvarial cells derived compound heterozygous
Pkd1
+/D;Kif3a
+/D mice had alkaline phosphatase activity, mineral-
ization and expression of Runx2 and osteocalcin transcripts that
did not differ from wild-type control cultures (Fig. 3C–3F).
Moreover, adipogenic gene expression (i.e., PPARc and aP2) that
was increased in Pkd1
+/D derived calvarial cells was suppressed in
compound heterozygous Pkd1
+/D;Kif3a
+/D cultures to levels not
significantly different from Kif3a
+/D –derived cells (Fig. 3F),
consistent with a predominant role of Kif3a deficiency to regulate
adipogenesis.
To further investigate the effects of Pkd1 or/and Kif3a deficiency
on the adipogenesis potential, we investigated the adipogenic
potential of bone marrow-derived mesenchymal stem cells
(BMSC) derived from wild-type, heterozygous Pkd1
+/D, heterozy-
gous Kif3a
+/D, and double heterozygous (Pkd1
+/D;Kif3a
+/D) mice
grown in the presence of rosiglitazone [44]. Under these
conditions, BMSC derived from wild-type mice cultures exhibited
a low density of Oil Red O staining adipocytes. Single
heterozygous Pkd1
+/D mice exhibited a marked increase in
adipogenic cells as evidenced by cells with lipid droplet formation
(Fig. 4A–4B). There was no significant difference in adipocyte
formation between single Kif3a
+/D and wild-type BMSC cultures.
However, superimposed Kif3a deficiency entirely reversed the
Table 1. Gene-expression profiles in 6-week-old mice.
Gene Accession no. Pkd1
+/D Kif3a
+/D Pkd1
+/D;Kif3a
+/D p-value
Osteoblast lineage
Runx2 NM_009820 0.5160.13* 1.3560.48 0.9360.11 0.0049
Osterix NM_130458 0.5460.13* 1.4260.13 1.0360.29 0.0033
Osteocalcin NM_007541 0.5260.09* 1.4560.39 1.1660.21 0.0071
Opg MMU94331 0.6760.08* 1.2360.22 1.2460.19 0.0129
Rank ligand NM_011613 0.5760.08* 0.9760.09 1.1260.21 0.0074
Dmp1 MMU242625 0.6560.11* 0.9460.18 1.2260.16 0.0060
Osteoclast
Trap NM_007388 0.2960.14* 0.6860.12 0.7660.22 0.0051
Mmp9 NM_013599 0.6760.11* 0.9760.14 1.0260.25 0.0246
Adipocyte
PPARc NM_009505 1.5760.24* 1.1060.27 1.1160.18 0.0090
aP2 NM_024406 0.9160.14 0.5960.16
# 0.9960.29 0.0292
Lpl NM_008509 1.3160.15* 0.7660.06
# 0.9260.15 0.0003
Adiponectin NM_009605 1.4260.34* 0.6560.11
# 0.9260.16 0.0015
Data are mean 6S.D. from 5–6 tibias of 6-week-old individual mice and expressed as the fold changes relative to the housekeeping gene cyclophilin A subsequently
normalized to wild-type mice.
*indicates significant difference from wild-type, and
#indicates significant difference from single heterozygous Kif3a
+/D, and double heterozygous Pkd1
+/D;Kif3a
+/D mice at p,0.05, respectively.
doi:10.1371/journal.pone.0015240.t001
deficiency on bone structure in compound Pkd1
+/D and Kif3a
+/D heterozygous mice. (C) Effects of Pkd1 or/and Kif3a on MAR at 6 weeks of age.
Compared with age-matched wild-type, single heterozygous Pkd1
+/D mice had a significant reduction in periosteal MAR of tibiae. In contrast, there
were no significant changes in the tibia MAR in single heterozygous Kif3a
+/D mice. However, the tibia MAR totally become normal in double
heterozygous Pkd1
+/D; Kif3a
+/D mice. Data are expressed as the mean6SD from 5 to 6 individual mice. Values sharing the same superscript are not
significantly different at P,0.05. * indicates significant difference from wild type, single heterozygous Kif3a
+/D, and compound heterozygous
Pkd1
+/D;Kif3a
+/D mice at p,0.05.
doi:10.1371/journal.pone.0015240.g002
Regulation of Gli2 Expression by Kif3a and Pkd1
PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15240Figure 3. Effects of Pkd1 or/and Kif3a deficiency on osteoblastic differentiation and maturation ex vivo. (A) ALP activity. Single Pkd1
+/D
osteoblasts displayed time-dependent increments in ALP activities, but the ALP activity was significantly lower at different time points during 14 days
of culture compared with wild-type control. In contrast, single Kif3a
+/D osteoblasts exhibited normal time-dependent increments in ALP activity and
had no difference at the time-matched points with control. However, Kif3a deficiency predominated over the effects of Pkd1 deficiency on ALP
activity in compound Pkd1
+/D;Kif3a
+/D osteoblasts. (B) Quantification of mineralization. Single Pkd1
+/D osteoblasts had time-dependent increments in
calcified nodule formation as measured by Alizarin Red-S staining, but the calcified nodules was significantly lower at 21 days of culture compared
with wild-type control. In contrast, single Kif3a
+/D osteoblasts exhibited normal time-dependent increments in calcified nodule formation and Kif3a
deficiency predominated over the effects of Pkd1 deficiency on calcified nodule formation in compound Pkd1
+/D and Kif3a
+/D osteoblasts. (C–D)
Osteogenic and adipogenic gene expression profiles by real-time RT-PCR. Single Pkd1
+/D osteoblasts in osteogenic medium showed a significant
attenuation in osteogenesis, evidenced by a significant reduction in osteoblastic markers such as Runx2 and Osteocalcin expressions (C), whereas a
markedly increase of adipocyte markers such as PPARc and aP2 (D) was observed when compared with wild-type control. In contrast, there was no
obvious difference in osteoblast-lineage markers between single Kif3a
+/D and wild-type osteoblast cultures, but a significant decrease in adipocyte
markers was observed in single Kif3a
+/D osteoblast cultures compared with wild-type control. Kif3a deficiency predominated over the effects of Pkd1
deficiency on osteogenic differentiation but retained less adipogenesis potentials in compound Pkd1
+/D and Kif3a
+/D osteoblast cultures. (E) Western
blot analysis. Phosphorylated Akt at Ser473 (panel 1), total Akt (panel 2), and b-actin (panel 3) levels in the cytoplasm from cultured osteoblasts were
detected by Western blot. Single heterozygous Pkd1
+/D cells displayed the decreased phosphorylation of the Akt compared with wild-type control,
whereas single heterozygous Kif3a
+/D had no changes, and compound heterozygous Pkd1
+/D;Kif3a
+/D cells become normal. Data are expressed as the
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BMSC derived from compound Pkd1
+/D;Kif3a
+/D BMSC cultures
(Fig. 4A–4B).
Role of hedgehog/Gli2 signaling in Pkd1 or/and Kif3a
deficiency mice
Since heterozygous deficiency of Kif3a failed to alter primary
cilia formation or Pkd1 expression (Fig. 1E, vide supra), we explored
the potential role of hedgehog signaling pathway in mediating the
effects of Kif3a deficiency to rescue skeletal abnormalities in
heterozygous Pkd1
+/D mice. As a measure of Hedgehog pathway
activity in the various mouse models, we assessed expression of
total Gli2 transcripts using total RNA from tibias and cultured
osteoblasts. We found that Gli2 expression was significantly
increased in single heterozygous Kif3a
+/D mice compared to wild-
type controls (Fig. 5A–5B). Although most studies show that
mutations in IFT proteins, including Kif3a, result in a down-
regulation of Hedgehog signaling [45,46,47], inactivation of Kif3a
has been reported to paradoxically increase Hedgehog pathway
activity in certain tissues, including cranial neural crest cells and
the limb [45,48,49]. In contrast, we found a significant reduction
of Gli2 expression in whole tibias and calvarial-derived osteoblasts
from single heterozygous Pkd1
+/D mice compared to wild-type
mice. The effect of Pkd1 deficiency to suppress Gli2 expression
was completely reversed in bone and calvarial cultures derived
from compound heterozygous Pkd1
+/D;Kif3a
+/D mice (Fig. 5A and
5B).
C3H10T1/2 cells are multipotent cells capable of developing
into osteoblast and adipocyte lineages [44,50]. To determine if
Gli2 mediates the observed effects on osteoblastic and adipocytic
differentiation, we overexpressed Gli2 transcription factor in
C3H10T1/2 cells (Fig. 5C). We found that Gli2 significantly
stimulates Runx2-P1 promoter activity, but suppresses PPARc2
promoter activity in these cells (Fig. 5C). Administration of sonic
hedgehog (Shh, 1 mg/ml) resulted in an increase of Runx2-P1
promoter activity but decrease of PPARc2 promoter activity in
C3H10T1/2 cells (Fig. 5D). C3H10T1/2 cells treated with Shh
(1 mg/ml) also displayed increases in Gli2 and Runx2-II gene
expression, no changes in Gli3 transcripts, and decrease of
PPARc2 message expression (Fig. 5E–5F).To further investigate if
PC1 has a direct effect on Runx2-P1 and PPARc2 promoter
activity, we overexpressed gain-of-function PC1 C-tail construct
(PC1-AT) in C3H10T1/2 cells (Fig. 5G). We found that PC1-AT
significantly stimulates Runx2-P1 promoter activity, but suppresses
PPARc2 promoter activity in these cells (Fig. 5G). In addition,
PC1-AT significantly increases Gli2 and Runx2-II mRNA expres-
sion in C3H10T1/2 cells (Fig. 5H), further supporting a role
of PC1-Gli2-Runx2 (PPARc) signaling in osteogenesis and
adipogenesis.
Discussion
We previously reported the presence and co-localization of
polycystins and primary cilia in osteoblasts [8] and proposed that
polycystins and primary cilia have an interdependent role in
regulating osteoblast differentiation and skeletal development [9].
In the current study, we attempted to assess the interaction
between Pkd1 and primary cilia by disrupting Kif3a in Pkd1-
deficient mice. We created new mouse models of Pkd1 and Kif3a
deficiency by crossing CMV-Cre with either Pkd1
flox/+ mice to
achieve a germline deletion of exon 2–4 or Kif3a
flox/+ mice to
attain deletion of exon 2 [51]. Quantitative RT-PCR analysis
revealed that the expression of total Pkd1 transcripts in single
Pkd1
+/D heterozygous mice was reduced by ,50% compared to
wild-type control. We found that this reduction in Pkd1 expression
in heterozygous Pkd1
+/D mice was sufficient to cause osteopenia
due to impairment of osteoblast-mediated bone formation and
enhanced adipocyte differentiation. These results are in agreement
with our previous reports in heterozygous Pkd1
+/m1Bei and
conditional Pkd1
Oc-cKO null mice [33,34], indicating that Pkd1
deficiency favors adipogenesis but inhibits osteogenesis in bone
tissues. In contrast, we found that single global Kif3a
+/D
heterozygous mice had no demonstrable bone or kidney
phenotype, even though the level of total Kif3a transcripts from
tibias and cultured osteoblasts was decreased by ,50%. Hence,
haploinsufficiency of Pkd1 had greater effects on bone than partial
deficiency of Kif3a.
Our apriori assumption was that an interaction between primary
cilia and Pkd1 would be revealed by additive effects of Kif3a
deficiency to worsen the effects of Pkd1-deficiency to impair bone
development in compound Pkd1
+/D;Kif3a
+/D mice. We found,
however, the opposite result. Superimposed Kif3a deficiency in
compound Pkd1
+/D;Kif3a
+/D mice rescued the skeletal abnormal-
ities and defects in osteoblast differentiation observed in Pkd1
+/D
mice. Indeed, reduction of Kif3a in compound Pkd1
+/D;Kif3a
+/D
mice completely reversed the effects of deficiency of Pkd1 on bone
mass and osteoblast and adipocyte differentiation, indicating
deficiency of Kif3a rescues the bone effects of Pkd1 haploinsuffi-
ciency. In addition, neither single Pkd1 and Kif3a nor double Pkd1
and Kif3a mutant mice developed polycystic kidney disease, unlike
the reported additive effects of Pkd1 and Pkd2 deficiency to
enhance renal cyst formation [52].
This salutary effect of Kif3a deficiency was associated with
alterations in the osteogenic and adipogenic pathways. Whereas
calvarial and bone marrow derived cells from heterozygous
Pkd1
+/D mice had impaired osteoblastic and increased adipocytic
differentiation in culture associated with decreased Runx2 and
increased PPARc expression, superimposed Kif3a
+/D deficiency
increased Runx2 and decreased PPARc expression restoring the
normal balance between osteogenic and adipogenic differentiation
pathways. Thus, rather than primary cilia and Pkd1 interactions
Table 2. Biochemistry analysis of serum in 6-week-old mice.
Genotype Wild-type Pkd1
+/D Kif3a
+/D Pkd1
+/D;Kif3a
+/D
BUN(mg/dl) 2061.7 1863.8 2363.1 1962.5
Ca (mg/dl) 9.260.29 9.160.19 9.060.21 8.960.26
P (mg/dl) 8.160.52 7.960.67 8.560.93 7.860.54
Osteocalcin
(gg/ml)
5562.3 4563.9* 5664.1 5262.9
TRAP (U/L) 2.160.18 1.660.02* 1.960.06 1.960.11
Data are mean 6S.D. from 4–6 individual mice.
*indicates significant difference from wild-type, single heterozygous Kif3a
+/D,
and double heterozygous Pkd1
+/D;Kif3a
+/D mice at p,0.05, respectively.
Osteocalcin is produced by osteoblasts, and TRAP is produced by osteoclasts.
doi:10.1371/journal.pone.0015240.t002
mean6SD from triple three independent experiments. Values sharing the same superscript are not significantly different at P,0.05. * indicates
significant difference from wild type, single heterozygous Kif3a
+/D, and compound heterozygous Pkd1
+/D;Kif3a
+/D mice at p,0.05.
doi:10.1371/journal.pone.0015240.g003
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cilia have counter regulatory effects on skeletogenesis.
We have previously shown that loss of Pkd1 inhibits osteoblast
development through reductions in intracellular calcium-mediated
Runx2 expression [33] and that primary osteoblasts derived from
conditional Pkd1
Oc-Cre null mice displayed impaired osteoblastic
differentiation and enhanced adipogenesis via suppression of
PI3K-Akt-Gsk3b-b-catenin signaling pathway [34]. In the current
study, we have found evidence that Hedgehog (Hh)/Gli signaling
is a possible mechanism mediating the interactions between Pkd1
and Kif3a on skeletogenesis. Even though partial deficiency of
Kif3a did not affect primary cilia number or formation,
haploinsufficiency of Kif3a might disrupt IFT necessary for
normal hedgehog signaling [18,45,51,53,54,55], which in turn
could counter the effects of deficiency of Pkd1 signaling [56,57]. In
this regard, Gli2 expression was reduced in both bone and
cultured primary osteoblasts from single Pkd1
+/D heterozygous
mice, but was normalized in compound Pkd1
+/D;Kif3a
+/D hetero-
zygous mice. Since inhibition of microtubule assembly in
osteoblasts is reported to stimulate the hedgehog signaling
Figure 4. Effects of Pkd1 or/and Kif3a deficiency on adipocytic differentiation in BMSC cultures. (A) Representative cells were stained with
Oil Red O in 10-days cultured Pkd1
+/D or/and Kif3a
+/D BMSCs as described in Materials and Methods. (B) Relative Oil Red O absorbance from above
indicated cultures. Stained lipid was extracted and the absorbance at 510 nm was measured. Clearly, there was a significant increase of adipogenesis
potential in single Pkd1
+/D BMSC cultures, Kif3a deficiency entirely reversed the effects of Pkd1 deficiency on adipogenesis potentials in compound
Pkd1
+/D;Kif3a
+/D BMSC cultures. There was no significant difference in adipocytic differentiation between single Kif3a
+/D and wild-type BMSC cultures.
Data are expressed as the mean6SD from triple three independent experiments. Values sharing the same superscript are not significantly different at
P,0.05.
doi:10.1371/journal.pone.0015240.g004
Regulation of Gli2 Expression by Kif3a and Pkd1
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15240Figure 5. The potential role of hedgehog/Gli2 signaling in Pkd1 or/and Kif3a deficient mice. (A–B) Expression of total Gli2 transcripts in the
tibias (A) and 10 days osteoblast cultures (B) by real-time RT-PCR. A significant reduction of Gli2 expression was observed in tibias and osteoblasts
from single heterozygous Pkd1
+/D mice when compared with other three groups. In contrast, a markedly increase of Gli2 expression was found in
single heterozygous Kif3a
+/D mice compared to control and other groups. (C) Effects of Gli2 on Runx2-P1 and PPARc2 promoter activity.
Overexpression of Gli2 results in up-regulation of Runx2-P1 promoter activity but down-regulation of PPARc2 promoter activity in C3H10T1/2 cells. (D)
Effects of Shh on Runx2-P1 and PPARc2 promoter activity. Consistent with the effects of Gli2, administration of Shh (1 mg/ml) results in up-regulation
of Runx2-P1 promoter activity but down-regulation of PPARc2 promoter activity in C3H10T1/2 cells. (E–F) Effects of Shh on Gli2, Gli3, Runx2-II, and
PPARc2 expressions in C3H10T1/2 cells. Consistent with promoter activity data, administration of Shh (1 mg/ml) increases Gli2 and Runx2-II transcripts,
have no changes in Gli3 mRNA message, but decreases PPARc2 gene expression in C3H10T1/2 cell cultures. (G–H) Effects of PC1 C-tail construct on
Gli2, Runx2-II, and PPARc2 expressions in C3H10T1/2 cells. Gain of function PC1 C-tail construct (PC1-AT) stimulated Runx2-P1 promoter activity but
inhibited PPARc2 promoter activity. Consistent with tibias and primary osteoblasts data, Gli2 and Runx2-II transcripts were significantly increased in
C3H10T1/2 cells, which were transiently transfected with PC1-AT for 48 hours. The slgØ construct was served as vector control. Data are expressed as
the mean6SD from triple three independent experiments. Values sharing the same superscript are not significantly different at P,0.05.
doi:10.1371/journal.pone.0015240.g005
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Kif3a
+/D heterozygous mice may have offset the effects of Pkd1
haploinsufficiency. Indeed, we found that overexpression of gain-
of-function PC1 C-tail construct promotes Gli2 and Runx2-II
expression, and we also observed that administration of Shh or
overexpression of Gli2 up-regulates Runx2-P1 promoter activity
and expression, consistent with a stimulatory role of Gli2
hedgehog signaling in osteoblast differentiation and bone devel-
opment [22,59,60,61]. In contrast, either administration of Shh or
overexpression of Gli2 or gain-of-function PC1 C-tail construct
down-regulates PPARc2 promoter activity and expression, consis-
tent with an inhibitory function of Gli2 hedgehog signaling on
adipogenesis and fat formation [22,23,62,63,64]. In agreement
with these findings, knock-down of Kif3a by siRNA suppresses
adipocyte differentiation in 3T3-L1 preadipocyte cultures [7].
Kif3a deficiency reduces expression of PPARc and CEBPa ´ proteins
and has anti-adipogenic role in 3T3-L1 adipogenic cells [7]. Since
adipogenesis and osteogenesis are inversely related [65,66,67], the
reduced adipogenesis in Kif3a haploinsufficient mice may have
promoted osteoblasts differentiation to offset the effects of
deficiency of Pkd1. In support of this hypothesis, we found that
Pkd1 and Kif3a haploinsufficiency had opposite effects on
adipogenic and osteogenic transcription factors and related gene
expressions. Kif3a
+/D heterozygous mice exhibited significant
reductions in adipocyte-related markers such as PPARc and aP2,
whereas Pkd1 deficient mice had reductions in osteoblastic
markers such as Runx2 and Osteocalcin expression, indicating a
counterbalance mechanism involved in Pkd1 and Kif3a haploin-
sufficient mice. These findings suggest that Pkd1 or/and Kif3a
deficiency might affect cell fate decision between osteoblastogen-
esis and adipogenesis through regulation of hedgehog signaling
pathway.
Kif3a mediates intraflagellar transport (IFT), which is necessary
for normal formation of the appendicular skeleton through
hedgehog signaling pathways [2,4,19]. Intraflagellar transport
has been shown to be essential for both endochondral bone
formation as well as perichondral bone formation, which is a form
of intramembranous bone formation. This suggests that IFT may
be important in both chondrocytic and osteoblastic lineages, a
finding supported by abnormalities of intramembranous bone
formation observed in mice after the conditional deletion of Kif3a
or Tg737 in mesenchymal skeletal progenitor cells [3,4,5,19].
While most studies suggest that inactivation of Kif3a reduces Hh
signal transduction [45,46,47,53], Kif3a may also activate Hh
signaling pathways in some settings [68], as we observed in
heterozygous Kif3a
+/D mice. For example, conditional deletion of
Kif3a in chondrocytes stimulates Indian hedgehog (Ihh) expression
in the perichondrium [4]. Also, conditional deletion of Kif3a in
neural crest cells, which give rise to the facial skeleton, leads to
gain of Hedgehog function that results in hypertelorism and
iprosopus [48]. Other observations indicate that Kif3a and other
IFT mutations can have paradoxical effects on hedgehog signaling
[45,49]. This inconsistency has been attributed to the differential
effects of Gli proteins (i.e., Gli1, Gli2, or Gli3) that may
predominate in different tissues [18,45,53,69].
Another possible explanation for the offsetting effects of Kif3a
deficiency to alter the bone phenotype in Pkd1 haploinsufficient
mice may be due to Kif3a altering the amount of Pkd1 in primary
cilia. This possibility is supported by the fact that Kif3a binds to
Pkd2 and regulates the amount of Pkd2 localized in primary cilia
[70,71] and the related observation that the ratio of Pkd1 and
Pkd2 determines the net function of the polycystins [72]. Thus,
deficiency of Kif3a may lead to a disproportionate reduction in
Pkd2 compared to Pkd1 in combined Kif3a/Pkd1 mutant mice,
leading to ‘‘normalization’’ of the polycystin signaling by restoring
the ratio of Pkd1 and Pkd2 in primary cilia. Consistent with this
possibility, transferring Kif3a-deficiency onto Pkd1-deficiency
restores PI3K-Akt signaling in bone and osteoblasts (Fig. 3E).
In summary, Kif3a haploinsufficiency counteracts the negative
effects of Pkd1 deficiency on osteoblast function, indicating an
interdependent relationship between Pkd1 and Kif3a in postnatal
bone formation. While the precise mechanism remains to be
defined, Kif3a haploinsufficiency up-regulates hedgehog/Gli2
signaling pathways, leading to both increased Runx2 and
osteoblastogenesis and significant inhibition of PPARc and
adiopogenesis. In contrast, Pkd1 haploinsufficiency inhibits hedge-
hog/Gli2 signaling, Runx2 expression and osteogenesis but
increases PPARc and adiopogenesis. Thus, cross-talk between
Pkd1 and Kif3a may play a counterbalancing role on bone
formation through the differential regulation of ostoegenesis and
adipogenesis in bone. These findings suggest that activation of
hedgehog/Gli2 signaling may provide a mechanism to counteract
the effects of lost Pkd1 signaling in bone and possibly other tissues,
such as the kidney, where defective hedgehog signaling is
associated with cystic kidney disease in Oral-facial-digital syn-
drome type 1 [73]. With regards to our original question of the
interdependence of polycystin and primary cilia function in
osteoblast development, additional experimental approaches to
more completely ablate Kif3a and/or primary cilia in the
osteoblasts lineage will be required.
Materials and Methods
Mice
We obtained the floxed Pkd1 mouse (Pkd1
flox/flox) which harbors
two loxP sites flanking exon 2–4 of the Pkd1 gene from Dr. Gregory
Germino at Johns Hopkins University [74], the floxed Kif3a mouse
(Kif3a
flox/flox) which contains two loxP sites flanking exon 2 of the
Kif3a gene from Lawrence S.B. Goldstein at University of
California, San Diego [39], and CMV-Cre transgenic mouse from
the Jackson Laboratory. We crossed the floxed Pkd1
flox/flox or
Kif3a
flox/flox mouse with CMV-Cre mouse to generate global Pkd1
(CMV-Cre;Pkd1
+/D)o rKif3a heterozygous (CMV-Cre;Kif3a
+/D)
mice. The resulting CMV-Cre;Pkd1
+/D or CMV-Cre;Kif3a
+/D mice
were then crossed to wild-type mice to segregate the CMV-Cre
transgene from the desired conditional null allele (Pkd1
D or Kif3a
D
as shown in Fig. 1A, equivalent to the Pkd1 or Kif3a null allele).
These mice were bred and maintained on a C57BL/6J
background at least in six generations. Then heterozygous
Pkd1
+/D mice were mated with heterozygous Kif3a
+/D mice to
generate wild-type, heterozygous Pkd1
+/D, heterozygous Kif3a
+/D,
and double heterozygous (Pkd1
+/D;Kif3a
+/D) mice. These mice
were used for phenotypic analysis. All animal research was
conducted according to guidelines provided by the National
Institute of Health and the Institute of Laboratory Animal
Resources, National Research Council. The University of
Tennessee Health Science Center’s Animal Care and Use
Committee approved all animal studies (Protocol number:
1885R2).
Genotyping PCR
Genomic DNA was prepared from tail specimens using
standard procedures [33]. Genotyping PCR was performed using
the following primers as previously described [39,51,74]: Pkd1
wild-type allele, F1, 59-AAT AGG GGT GGG GCT TGT GGG
TCG-39, R1, 59-TAC TCA CAC CTC CAC CAG TGC-39; Pkd1
conditional null allele, F2, 59-CGA CCA CCA AGC GAA ACA
TC-39; R2, 59-TCG TGT TCC CTT ACC AAC CCT C-39;
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G-39, R3, 59-TCT GTG AGT TTG TGA CCA GCC-39; Kif3a
conditional null allele F3, 59-AGG GCA GAC GGA AGG GTG
G-39, R4, 59-TGG CAG GTC AAT GGA CGC AG-39. Pkd1
wild-type and null alleles were identified in 2% agarose gel as 250-
bp and 850-bp bands (Fig. 1B, upper two panels), while Kif3a wild-
type and null alleles were detected as 360-bp and 200-bp bands
(Fig. 1B, lower two panels), respectively.
Bone Densitometry, histomorphometric and Micro-CT
analysis
BMD of femur from 6-week-old mice were scanned using a
PIXImus bone densitometer (Lunar Corporation, Madison, WI)
with dual-energy X-ray absorptiometry technology. BMD within a
defined area of the whole femur was analyzed using proprietary
Lunar PIXImus software. Calcein (Sigma, St. Louise, MO) double
labeling of bone and histomorphometric analyses of periosteal
MAR in tibias were performed using the osteomeasure analysis
system (Osteometrics) [75,76]. Femurs were isolated from 6-week-
old mice and fixed in 70% ethanol for mCT analysis. The long axis
of the femur was oriented orthogonally to the rotation axis of the
scanner. Entire femur scans were performed at an isotropic voxel
size of 12 mM using a mCT 40 scanner (Scanco Medical AG,
Bru ¨ttisellen, Switzerland). A 3D image analysis was done to
determine BV/TV in the distal metaphyses and Ct.Th in the
midshaft of diaphyses area as previously described [8,33,75,77].
Quantitative Real-time RT-PCR
A 2.0 mg of total RNA were isolated from tibia of 6-week-old
mice or 10 days cultured primary osteoblasts in differentiation
media. The cDNAs were generated using a Reverse Transcriptase
Kit (Perkin-Elmer, Foster City, CA). PCR reactions contained 100
gg template (cRNA or cDNA), 200 gmol each forward and
reverse primers, 1X iQ
TM SYBR
H Green Supermix (Bio-Rad,
Hercules, CA) in 50 ml. The threshold cycle (Ct) of tested-gene
product from the indicated genotype was normalized to the Ct for
cyclophilin A as previously described [8,33,77]. Expression of total
Pkd1 transcripts was performed using the following Pkd1-specific
primers: forward primer of Pkd1 transcripts in exon 2-4, 59-TAG
GGC TCC TGG TGA ACC TT -39, and reverse primer of Pkd1
transcripts in exon 2-4, 59–CCA GAC CAC AGT TGC ACT CA-
39. Expression of total Kif3a transcripts was performed using the
following Kif3a-specific primers: forward primer of Kif3a tran-
scripts in exon 2, 59-GCT ATA GAC AGG CCG TCA GC-39,
and reverse primer of Kif3a transcripts in exon 2, 59–GTC TTT
GGA GGT TCG TTG GA-39. The value of Pkd1 or Kif3a vs.
cyclophilin A from the indicated genotype was normalized to the
mean ratio of 5 wild-type mice, which has been set to 1.
Primary Osteoblast Culture for Proliferation and
Differentiation, and western blot analysis
Primary osteoblasts were isolated from the newborn mouse
calvarias by sequential collagenase digestion at 37uC as previously
described [8,77]. The cells were cultured in alpha-minimal
essential medium (a-MEM) containing 10% fetal bovine serum
(FBS) and 1% penicillin and streptomycin (P/S). Cell proliferation
was detected by BrdU incorporation assays as the manufacturer
describes (QIA58, Calbiochem, Gibbstown, NJ). To induce
differentiation, primary osteoblasts were plated at a density of
2.5610
4 cells/cm
2 in a 6-well plate, and grown for period of up to
21 days in a-MEM containing 10% FBS supplemented with
5m M b-glyceropho-phate and 25 mg/ml of ascorbic acid.
Alkaline phosphatase activity and Alizarin red-S histochemical
staining for mineralization were performed as previously described
[8,77]. Total DNA content was measured with a PicoGreenH
dsDNA quantitation reagent and kit (Molecular Probes, Eugene,
OR). Protein concentrations of the supernatant were determined
with a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA).
To examine the amounts of cytoplasmic phosphorylated Akt,
we isolated cytoplasmic protein using NE-PER Nuclear and
Cytoplasmic Extraction Kit (Pierce Biotechnology, Rockford, IL)
according to the manufactory’s instruction. Protein concentrations
of the supernatant were determined with a Bio-Rad protein assay
kit (Bio-Rad, Hercules, CA). Equal quantities of protein were
subjected to NuPAGE
TM 4–12% Bis-Tris Gel (Invitrogen,
Carlsbad, CA) and were analyzed with standard Western blot
protocols (HRP-conjugated secondary antibodies from Santa Cruz
Biotechnology and ECL from Amersham Biosciences, Buckin-
ghamshire, UK). Antibodies against phospho-Akt (ser-473) and
Akt were from Cell Signaling Technology (Beverly, MA). Anti-b-
actin (sc-47778) antibodies were from Santa Cruz Biotechnology.
Transient transfection
Pluripotent C3H10T1/2 mesenchymal cells (American Type
Culture Collection, Manassas, VA) were maintained in Eagle’s
Minimum Essential Medium (EMEM) containing 10% FBS and
1% P/S. A 2,300 bp promoter region of PPARc2 gene was
amplified by polymerase chain reaction (PCR) using a set of
primers 59- TCC CCG GGG GTA TGT GG A GCC CA A CCC
A- 3 9 and 59- ACG TCG ACA GAT TTG CTG TAA TTC ACA
CTG G -39 containing SmaI and SalI sites and the resultant
product was subcloned into pluc4 luciferase reporter construct and
confirmed by subsequent analysis [78,79]. To examine if
hedgehog signaling regulates Runx2-P1 and PPARc2 promoter
activity, a number of 1610
6 of C3H10T1/2 cells were transfected
with either Runx2-P1 promoter luciferase reporter (p1.4Runx2-P1-
Luc) or PPARc2 promoter luciferase reporter (p2.3PPARc2-Luc)
conducted by electroporation using Cell Line Nucleofector Kit R
according to the manufacturer’s protocol (Amaxa Inc, Gaithers-
burg, MD). A total of 6.6 mg of plasmid DNA was used for each
electroporation, with 3.0 mg of pcDNA3.1 empty expression
vector, 3.0 mg of either p1.4Runx2-P1-Luc or p2.3PPARc2-Luc
reporter, and 0.6 mg of Renilla luciferase-null (RL-null) as internal
control plasmid. The cells were cultured in EMEM supplemented
with 1%FBS and promoter activity will be assessed by measuring
luciferase activity 72 hours after transfection in the presence or
absence of 1 mg/ml of recombinant mouse sonic hedgehog N-
terminus (Shh-N) treatment. The total RNA was also isolated for
real-time RT-PCR analysis. To examine if Gli2 or PC1 has a
direct effect on Runx2-P1 and PPARc2 promoter activity, a Gli2 or
PC1 C-tail (PC1-AT) expression construct along with either
p1.4Runx2-P1-Luc or p2.3PPARc2-Luc were co-transfected into
C3H10T1/2 cells. The cells were cultured for 48 hours in EMEM
supplemented with 1%FBS and the relative luciferase activities of
cell lysates were measured by a luciferase assay kit (Promega,
Madison, WI) and normalized with Renilla luciferase activity and
empty expression vector (pcDNA3.1 or sIgØ) as previously
described [8,33]. We also isolated the total RNAs for real-time
RT-PCR analysis.
Immunofluorescence
Primary osteoblasts were grown on collagen-coated 4-well
chamber at 1610
5 cells per well and kept at confluence for at least
3 days. At the end of the culture, the cells were washed three times
with PBS, then fixed with cold 4% paraformaldehyde/0.2%
Triton for 10 minutes at room temperature and washed with PBS
3 times. The cells were incubated for 30 minutes in 1% BSA
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antibody (1:4000, Sigma Aldrich, T6793) for 1 hour at room
temperature. After washing three times in PBS they were treated
with secondary Texas Red-labeled anti-mouse IgG (Jackson
ImmunoResearch, 715-076-150) in 1% BSA for 1 hour at room
temperature and washed three times in PBS before mounting with
ProLongH Gold antifade reagent (Invitrogen, P36935). Nuclei
were counter-stained with DAPI blue. Photographs were taken
under a microscope with magnifications of 406for counting the
number of primary cilia in cultured primary osteoblasts as
previously described [8].
Adipocyte Differentiation of Bone Marrow-derived
Mesenchymal Stem Cells
Primary BMSCs were harvested from the long bone of 8-week-
old mice as previously described [75]. Briefly, the epiphysis of long
bone was cut off, the bone marrow was flushed out with a-MEM
containing 10% FBS and 1% P/S and went through a 70-mm
filter mesh. The cells were plated in 100 mm culture dishes at a
density of 2.5610
7 cells per cm
2 and cultured in a humidified
incubator with 5% CO2 and 95% air at 37uC. On day 3, a half of
cultured medium was removed and replaced with fresh a-MEM
growth medium. On day 5, the adherent cells (representing
BMSCs) were detached with 0.25% trypsin/1 mM EDTA and
seeded onto 6-well plates at 3610
4 cells per well for up to 8 days.
To induce adipocyte differentiation, the BMSCs were treated with
adipogenic differentiation medium supplemented with 10% FBS,
5 mM beta-glycerophophate and 50 mg/ml of ascorbic acid for 4
days and then added 1 mmol/L rosiglitazone for another 8 days.
At the endpoint, the cells were processed for Oil Red O lipid
staining as previously described [44]. Breifly, the cells were rinsed
with 1xPBS and fixed with cold 4% paraformaldehyde solution for
1 hour at 4uC. The cells were rinsed with distilled water followed
by 60% isopropanol for 5 minutes at room temperature. Then the
cells were stained in 0.5% Oil Red O-isopropanol working
solution for 15 minutes at room temperature, differentiated in
60% isopropanol, and rinsed in tap water. For quantitative
analysis, Oil Red O was extracted with 1 ml 99% isopropanol for
2 min, and optical density of each sample was determined at
510 nm.
Serum Biochemistry
Serum osteocalcin levels were measured using a mouse
osteocalcin EIA kit (Biomedical Technologies Inc. Stoughton,
MA, USA). Serum urea nitrogen (BUN) was determined using a
BUN diagnostic kit from Pointe Scientific, Inc. Serum calcium
(Ca) was measured by the colorimetric cresolphthalein binding
method, and phosphorus (P) was measured by the phosphomo-
lybdate–ascorbic acid method (Stanbio Laboratory, TX, USA).
Serum TRAP was assayed with the ELISA-based SBA Sciences
mouseTRAP
TM assay (Immunodiagnostic Systems, Fountain
Hills, AZ).
Statistical Analysis
We evaluated differences between two groups by unpaired t-test
and multiple groups by one-way analysis of variance. All values are
expressed as means 6 S.D. All computations were performed
using the GraphPad Prism5 (GraphPad Software Inc. La Jolla,
CA).
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